Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
Work
Year: 2009
Type: article
Abstract: Background Sulindac is an FDA-approved non-steroidal anti-inflammatory drug (NSAID) that affects prostaglandin production by inhibiting cyclooxygenases (COX) 1 and 2. Sulindac has also been of interes... more
Source: PLoS ONE
Institution Florida Atlantic University
Cites: 40
Cited by: 57
Related to: 10
FWCI: 3.382
Citation percentile (by year/subfield): 91.73
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $1,805